原文摘录：See all DONs related to this event Read more about Ebola disease Situation at a glance Since the publication of the previous Disease Outbreak News on 23 October 2026, the Bundibugyo virus disease (BVD) outbreak has expanded geographically in the Democrati … item/2026-DON625
原文摘录：See all DONs related to this event Read more about Yellow fever Situation at a glance Yellow fever transmission continues in the WHO African Region, with recent outbreak activity concentrated in parts of West Africa. … item/2026-DON624
原文摘录：Rivaroxaban Viatris (previously Rivaroxaban Mylan) RSS Authorised This medicine is authorised for use in the European Union rivaroxaban Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview Rivaroxaban M … 21 MB - DOCX) First published: 04/06/2025 View This page was last updated on 06/11/2026
原文摘录：Yorvipath RSS Authorised This medicine is authorised for use in the European Union palopegteriparatide Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview Yorvipath is a hormone replacement medicine fo … 37 KB - PDF) First published: 15/09/2023 View News on Yorvipath Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15/09/2023 More information on Yorvipath EU/3/20/2350 - orphan designation for treatment of hypoparathyroidism EMA/PE/0000241327 - paediatric investigation plan A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide) - post-authorisation study A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding - post-authorisation study This page was last updated on 06/11/2026
原文摘录：Aldurazyme RSS Authorised This medicine is authorised for use in the European Union laronidase Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview This is a summary of the European public assessment re … This page was last updated on 06/11/2026
原文摘录：Bylvay RSS Authorised This medicine is authorised for use in the European Union odevixibat Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview Bylvay is a medicine for treating patients from the age of … More information on Bylvay EU/3/12/1028 - orphan designation for treatment of progressive familial intrahepatic cholestasis EU/3/12/1040 - orphan designation for treatment of Alagille syndrome EMEA-002054-PIP01-16-M03 - paediatric investigation plan EMA/PE/0000240317 - paediatric investigation plan Bylvay - withdrawal of application for variation to marketing authorisation Registry to Document Treatment Effectiveness, Safety, Including Prospective Long-term Outcomes in Participants with Progressive Familial Intrahepatic Cholestasis (PFIC) who take Odevixibat (Bylvay) - post-authorisation study Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS) - post-authorisation study Prospective Registry-Based Study of the Long-Term Safety of Odevixibat in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) - post-authorisation study This page was last updated on 06/11/2026
原文摘录：Entyvio RSS Authorised This medicine is authorised for use in the European Union vedolizumab Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview Entyvio is a medicine used to treat adult patients with … 73 KB - PDF) First published: 21/03/2014 Last updated: 21/03/2014 View News on Entyvio Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2021 17/12/2021 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2020 28/02/2020 European Medicines Agency recommends 39 medicines for human use for marketing authorisation in first half of 2014 10/07/2014 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 March 2014 21/03/2014 European Medicines Agency recommends approval of a locally targeted treatment for ulcerative colitis and Crohn's disease 21/03/2014 More information on Entyvio EMEA-000645-PIP03-18 - paediatric investigation plan EMEA-000645-PIP01-09-M09 - paediatric investigation plan EMEA-000645-PIP04-20-M02 - paediatric investigation plan Vedolizumab-4081: Infection Outcomes among Advanced Therapy-naive Older Adult US Patients With UC/CD Initiating ENTYVIO, TNF-alpha Inhibitors, or Ustekinumab: A Retrospective Observational Matched-Cohort Study Using Medicare Claims Data, 2016-2025 - post-authorisation study Vedolizumab-5001: Organization of Teratology Information Specialists (OTIS) Vedolizumab Pregnancy Exposure Registry - post-authorisation study Vedolizumab-5056: Clinical Effectiveness of Vedolizumab Used in Frames of Drug Program for Crohn’s Disease Treatment in Poland – Prospective, Observational Study Considering Fatigue and Other Patient-reported-outcomes (PROs) (POLONEZ II) - post-authorisation study Comparative Effectiveness of Tofacitinib Versus Ustekinumab and Vedolizumab among Ulcerative Colitis Patients With Prior Anti- Tumor Necrosis Factor (TNF) Failure - post-authorisation study Topics Medicines This page was last updated on 06/11/2026
原文摘录：Elaprase RSS Authorised This medicine is authorised for use in the European Union idursulfase Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview This is a summary of the European public assessment rep … This page was last updated on 06/11/2026
这是一篇关于新大陆螺旋蝇Cochliomyia hominivorax基因组学研究的综述。该虫幼虫为专性寄生，危害美洲畜禽、野生动物及偶发人类，曾经不育昆虫技术（SIT）从北美和中美根除，但2023年起重新入侵。完整基因组已更新至第二版，遗传工程性别分离品系正在开发，基因驱动处于早期阶段，基因组学进展可为下一代防控方案提供基础。
原文摘录：The purpose of this 1-year open-label extension study is to characterize the longer-term safety and tolerability of DDY391 and to assess the durability of clinical response in participants with Psoriatic Arthritis (PsA) who have completed treatment in the
原文摘录：Non-State actors information and engagement session 7 October 2026 Amid growing mistrust in science and widespread health misinformation, the WHO Civil Society Commission and the WHO Chief Scientist’s Office held an information session for non-State actor … int
原文摘录：Patients who prefer a language other than English (LOE) are underrepresented in clinical research trials. The reasons for lower enrollment are multi-faceted, and the literature lacks a good understanding of these causes or how to address them.
原文摘录：Dr Geetha Krishnan Gopalakrishna Pillai of WHO Global Centre for Traditional Medicine, delivering his keynote at FoodMed 2026 Conference The FoodMed Conference returned for its second edition on 5–6 November 2026, bringing together international experts,
原文摘录：UNLABELLED: Toxoplasma gondii infection is usually asymptomatic in immunocompetent individuals. However, primary infection during pregnancy can lead to severe fetal manifestations. … In addition, agreements with the Architect To
原文摘录：BACKGROUND: HDV infection represents a rare co-infection or super-infection among persons with HBV infection and is associated with significant morbidity and mortality due to an increased risk of liver events such as hepatic decompensation and HCC. … Recent advances in HDV treatment offer hope for meaningful improvement in clinical outcomes
原文摘录：On Monday, 9 November, health takes centre stage as the thirty-first session of the Conference of the Parties (COP31) to the UN Framework Convention on Climate Change (UNFCCC) opens with a dedicated Health Day. … ATACH and AIR give countries the means to do that, during COP31 and beyond
原文摘录：PURPOSE: Currently, PSMA- and CD70-targeted imaging are the main focuses in the molecular imaging of RCC, but these modalities have not been compared in clinical studies.
原文摘录：CONTEXT: There is limited data of the associations between sex hormones and muscle mass and physical function in men over 80 years old.
原文摘录：BACKGROUND: Helicobacter pylori eradication leads to complete tumor regression in most gastric mucosa-associated lymphoid tissue (MALT) lymphomas. … CONCLUSION: From six years after Helicobacter pylori eradication treatment, the risk of gastric MALT lymphoma was no longer higher than that of the background population
原文摘录：Email Bluesky Facebook LinkedIn Reddit Whatsapp X View saved research Paying researchers to review papers is seen as a potential solution to clearing the peer-reviewing backlog. … Shanghai, Beijing, Nanjing, New Delhi or Pune – hybrid working model Springer Nature Ltd Assistant Professor Positions at City University of Hong Kong (Dongguan) The University invites individuals from diverse backgrounds to apply for faculty positions in this field Dongguan, Guangdong, China City University of Hong Kong (Dongguan) Professor / Associate Professor Positions at City University of Hong Kong (Dongguan) The University invites individuals from diverse backgrounds to apply for faculty positions in this field Dongguan, Guangdong, China City University of Hong Kong (Dongguan) Chair Professor Positions at City University of Hong Kong (Dongguan) The University invites individuals from diverse backgrounds to apply for faculty positions in this field Dongguan, Guangdong, China City University of Hong Kong (Dongguan)
美国CDC为应对2024–2025年美洲Oropouche病毒疫情，评估了美国104例Oropouche病毒病患者特征并与266例检测阴性者比较症状组合的灵敏度与特异度。病例中发热占94%、头痛83%、肌痛78%，报告≥5种症状者65例；≥2种症状组合灵敏度99%但特异度仅7.5%，纳入旅行史后特异度升至61%。提示临床检测标准可根据监测目标调整。
原文摘录：BACKGROUND: Prior analyses of PALLAS (NCT02513394), a phase III trial that randomized patients with stage II-III hormone receptor-positive breast cancer to receive adjuvant palbociclib plus endocrine therapy (ET) or ET alone, did not show benefit of the c … gov, NCT02513394
关注理由：这条肿瘤学内容涉及随机对照研究，建议同时核对纳入人群、主要终点与报告结果。
原文摘录：BACKGROUND: Text message reminders (TMRs) and patient navigation (PN) increase bowel cancer screening uptake. To date, no studies have directly compared these interventions with one another. … TRIAL REGISTRATION: ISRCTN17245519
关注理由：关注肿瘤学时，这项随机对照研究可提供直接比较的证据，主要终点和研究局限需要一起阅读。
原文摘录：BACKGROUND: Undernutrition is the leading driver of tuberculosis worldwide, yet its effect on the lungs of people who complete treatment is not well defined. … Nutritional assessment belo
关注理由：这篇呼吸病学资料涉及队列研究，可从人群选择、随访时间和关联强度理解其发现。
原文摘录：OBJECTIVES: To evaluate long-term mortality among sepsis survivors in Catalonia over a 15-year period and to identify factors associated with increased mortality within 2 years after hospital discharge. DESIGN: Retrospective population-based cohort study.
关注理由：这篇感染病学队列研究资料适合了解长期变化，研究对象、随访方式和结局指标建议一起查看。
原文摘录：Divorce is among the most common and costly life disruptions adults may face. Maladaptive and ineffective couple communication is routinely implicated in leading models as the cause of divorce, and interventions designed to prevent divorce accordingly pri
原文摘录：BACKGROUND: Although minimally invasive repair of pectus excavatum (MIRPE) is associated with favorable outcomes, it remains generally unknown whether cardiac compression persists after bar removal.
原文摘录：Clinical guidelines generally favour coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI) as the revascularisation strategy of choice in patients with left main coronary artery disease. … 3 The PRECOMBAT trial4 and SYNTAX Extended Survival trial5 similarly demonstrated no significant differences in all-cause mortality at 10 years between patients who underwent PCI with first-generation drug-eluting stents and those who underwent CABG
关注理由：如果关注医学研究，这项随机对照研究的分组方式、主要终点和组间差异值得细读。
原文摘录：One in four adolescents worldwide reported not getting at least 60 minutes of physical activity on any day in the previous week. … Stand with science”, the theme of World Health Day 2026, marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide
关注理由：这条内分泌与代谢资料适合作为深入阅读入口，尤其要关注研究方法与结论是否匹配。
WHO候选疫苗优先技术咨询小组基于现有临床前和早期临床证据，建议将牛津大学与印度血清研究所的ChAdOx1及Moderna的mRNA-1469加入刚果（金）Tumaini试验，系针对Bundibugyo病毒的疫苗首次在疫情期间接受临床评估，待国家批准后入组。
关注理由：针对Bundibugyo病毒的候选疫苗首次在疫情期间进入临床评估，Tumaini多疫苗试验与治疗研究并行推进，结果时间表明确，可跟踪疫情期间疫苗评价模式的验证进展。
原文摘录：WHO / Monika Mey Local health workers in Cambodia are trained in surveillance techniques, including stool examination using Kato-Katz, to detect schistosomiasis eggs, identify potential hotspots and support early detection and treatment. … int Related Global report on neglected tropical diseases 2026 Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030 WHO's work on neglected tropical diseases More WHO Global Neglected Tropical Diseases Programme
关注理由：关于感染病学的这条内容有明确出处，主要发现和适用人群可在原文中继续核查。
原文摘录：OBJECTIVE: The aim of this study was to determine the efficacy and acceptability of targeted use of kudzu, an herbal supplement, in adults with alcohol use disorder (AUD) who binge drink. … Greater reductions in binge drinking and PEth were observed among those who took medication more frequently
原文摘录：Six proven climate and health measures could save 1.6 million lives a year while delivering trillions of dollars in economic and fiscal gains, according to a new World Health Organization (WHO) report released today.
关注理由：这条医学资料适合作为深入阅读入口，尤其要关注研究方法与结论是否匹配。
原文摘录：Truqap - withdrawal of application for variation to marketing authorisation Application withdrawn The application for a change to this medicine's authorisation has been withdrawn capivasertib Post-authorisation Human Overview AstraZeneca AB withdrew its a … News on Truqap Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026 16/10/2026 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024 26/04/2024 More information on Truqap Truqap This page was last updated on 03/11/2026
关注理由：这篇临床试验内容涉及随机对照研究，阅读重点可以放在研究分组、主要终点和随访结果上。
原文摘录：BACKGROUND: Transcatheter mitral valve replacement (TMVR) is an approved treatment option for select high-risk patients with symptomatic mitral regurgitation (MR). … 001) and a mean Kansas City Cardiomyopathy Questionnaire overall summary score inc
关注理由：关注心血管医学时，这项队列研究提供了人群层面的观察线索，随访质量和潜在偏倚值得继续核查。
原文摘录：See all DONs related to this event Situation at a glance On 20 October 2026, the National IHR Focal Point (NFP) of France notified WHO regarding the first documented human infection with Shamonda virus (SHAV). … item/2026-DON623
关注理由：这篇神经内科资料可用于了解领域进展，研究设计、结果和局限性值得一起阅读。
原文摘录：OBJECTIVE: To evaluate histologic cirrhosis regression after metabolic bariatric surgery (MBS) in patients with compensated metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis.
关注理由：这条消化与肝病资料涉及具体临床问题，研究人群、方法和结局指标可以结合原文进一步查看。
原文摘录：OBJECTIVE: The exocrine pancreas is increasingly implicated in type 1 diabetes. Noninvasive biomarkers of exocrine function, fecal elastase-1 (FE-1) and serum immunoreactive trypsin (IRT), may provide early insight into disease pathogenesis.
关注理由：关注诊断与检测时，这项队列研究提供了人群层面的观察线索，随访质量和潜在偏倚值得继续核查。
原文摘录：Image credit: © tadamichi | stock.adobe.com Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026 30 October 2026 PRAC starts review of depression and anxiety medicine Deanxit and a safety signal related to hu … eu All other enquiries please submit your request via the online form Follow us on Bluesky Related medicine information Flupentixol/melitracen-containing medicinal products - referral Topics Pharmacovigilance
关注理由：如果关注精神医学，这篇内容值得阅读其研究对象、方法设计和主要发现。
原文摘录：This recall involves implementing additional recommendations on the use of the StatStrip Glucose Hospital Meter System while awaiting a software update. … 10/20/2026 The FDA issued a communication notifying the public of a Class I Recall
关注理由：这篇内分泌与代谢内容涉及具体研究方向，原文中的样本、结局和限制有助于理解其价值。